GLP-1 Medications Reduce Binge Eating Symptoms
Summary: A systematic review and meta-analysis led by University College London (UCL) found that GLP-1 receptor agonists—medications such as semaglutide, tirzepatide and liraglutide—produce more than just weight loss. The evidence indicates these drugs substantially reduce core symptoms of binge eating disorder (BED), including the frequency of binge episodes, loss-of-control eating and emotional eating, while also … Read more